Literature DB >> 27980276

Multiple Deep Vein Thrombosis.

Shumpei Onishi1, Toshihisa Ichiba, Hiroshi Naito.   

Abstract

Entities:  

Year:  2016        PMID: 27980276      PMCID: PMC5283976          DOI: 10.2169/internalmedicine.55.7691

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 46-year-old woman with a history of abnormal vaginal bleeding and who was taking oral contraceptive pills presented to the emergency department complaining of pain in her upper and lower extremities. Three weeks previously, she had experienced pain and swelling in her left lower extremity. Ten days previously, she had experienced left neck pain and facial swelling, but the symptoms disappeared a few days later. She subsequently experienced pain in her left upper extremity. Contrast-enhanced computed tomography (CT) showed deep vein thrombosis (DVT) in the internal jugular vein with extension to the left brachiocephalic and subclavian veins (Picture A and B). The CT scan also showed pulmonary embolism (Picture C), DVT in the left lower extremity, and the mass of an endometrial carcinoma (Picture D). Hormone replacement therapy and cancer increase the risk of multiple vein thrombosis (1, 2). She stopped taking the contraceptive pills, and anticoagulation therapy was initiated.
Picture.
  2 in total

1.  Prospective evaluation of combined upper and lower extremity DVT.

Authors:  Anil P Hingorani; Enrico Ascher; Natalia Markevich; Richard W Schutzer; Sreedhar Kallakuri; Manikyam Mutyala; Suresh Nahata; William Yorkovich; Theresa Jacob
Journal:  Vasc Endovascular Surg       Date:  2006 Mar-Apr       Impact factor: 1.089

2.  Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.

Authors:  S Sweetland; V Beral; A Balkwill; B Liu; V S Benson; M Canonico; J Green; G K Reeves
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.